RESUMEN
PURPOSE: Mitigating coupling effects between coil elements represents a continuing challenge. Here, we present a 16-bowtie slot volume coil arranged in eight independent dual-slot modules without the use of any decoupling circuits. METHODS: Two electrically short "bowtie" slot antennas were used to form a "module." A bowtie configuration was chosen because electromagnetic modeling results show that bowtie slots exhibit improved B 1 + P in $$ \frac{B_1^{+}}{\sqrt{P_{in}}} $$ efficiency when compared to thin rectangular slots. An eight-module volume coil was evaluated through electromagnetic modeling, bench tests, and MRI experiments at 4.7 T. RESULTS: Bench tests indicate that worst-case coupling between modules did not exceed -14.5 dB. MR images demonstrate well-localized patterns about single excited modules confirming the low coupling between modules. Homogeneous MR images were acquired from a synthesized quadrature birdcage transmit mode. MRI experiments show that the RF power requirements for the proposed coil are 9.2 times more than a birdcage coil. Whereas from simulations performed to assess the proposed coil losses, the total power dissipated in the phantom was 1.1 times more for the birdcage. Simulation results at 7 T reveal an equivalent B1 + homogeneity when compared with an eight-dipole coil. CONCLUSION: Although exhibiting higher RF power requirements, as a transmit coil when the power availability is not a restriction, the inherently low coupling between electrically short slots should enable the use of many slot elements around the imaging volume. The slot module described in this paper should be useful in the design of multi-channel transmit coils.
Asunto(s)
Imagen por Resonancia Magnética , Ondas de Radio , Imagen por Resonancia Magnética/métodos , Simulación por Computador , Fantasmas de Imagen , Electricidad , Diseño de EquipoRESUMEN
Helicobacter pylori infection usually causes gastrointestinal complications, including gastrointestinal bleeding or perforation, and serious infections may lead to gastric cancer. Amoxicillin is used to treat numerous bacterial infections but is easily decomposed in the gastric acid environment via the hydrolyzation of the ß-lactam ring. In this study, we develop chitosan-based nanoparticles loaded with amoxicillin (CAANs) as an H. pylori eradication platform. The CAANs were biocompatible and could retain the antibiotic activity of amoxicillin against H. pylori growth. The mucoadhesive property of chitosan and alginate enabled the CAANs to adhere to the mucus layers and penetrate through these to release amoxicillin in the space between the layers and the gastric epithelium. The use of this nanoparticle could prolong the retention time and preserve the antibiotic activity of amoxicillin in the stomach and help enhance the eradication rate of H. pylori and reduce treatment time. These CAANs, therefore, show potential for the effective treatment of highly antibiotic-resistant H. pylori infection using amoxicillin.
RESUMEN
Aim: 7-Ethyl-10-hydroxycamptothecin (SN-38)-loaded gold nanoshells nanoparticles (HSP@Au NPs) were developed for combined chemo-photothermal therapy to treat colorectal cancer. Materials & methods: SN-38-loaded nanoparticles (HSP NPs) were prepared by the lyophilization-hydration method, and then developed into gold nanoshells. The nanoparticles were characterized and assessed for photothermal properties, cytotoxicity and hemocompatibility in vitro. In vivo anticancer activity was tested in a tumor mouse model. Results: The HSP@Au NPs (diameter 186.9 nm, zeta potential 33.4 mV) led to significant cytotoxicity in cancer cells exposed to a near-infrared laser. Moreover, the HSP@Au NP-mediated chemo-photothermal therapy displayed significant tumor growth suppression and disappearance (25% of tumor clearance rate) without adverse side effects in vivo. Conclusion: HSP@Au NPs may be promising in the treatment of colorectal cancer in the future.
Asunto(s)
Neoplasias Colorrectales , Nanocáscaras , Animales , Línea Celular Tumoral , Neoplasias Colorrectales/tratamiento farmacológico , Doxorrubicina/uso terapéutico , Irinotecán , Ratones , Fototerapia , Terapia FototérmicaRESUMEN
BACKGROUND: Lung cancer is the leading cause of cancer patient death in the world. There are many treatment options for lung cancer, including surgery, radiation therapy, chemotherapy, targeted therapy, and combined therapy. Despite significant progress has been made in the diagnosis and treatment of lung cancer during the past few decades, the prognosis is still unsatisfactory. PURPOSE: To resolve the problem of chemotherapy failure, we developed a magnetite-based nanomedicine for chemotherapy acting synergistically with loco-regional hyperthermia. METHODS: The targeting carrier consisted of a complex of superparamagnetic iron oxide (SPIO) and poly(sodium styrene sulfonate) (PSS) at the core and a layer-by-layer shell with cisplatin (CDDP), together with methotrexate - human serum albumin conjugate (MTX-HSA conjugate) for lung cancer-specific targeting, referred to hereafter as SPIO@PSS/CDDP/HSA-MTX nanoparticles (NPs). RESULTS: SPIO@PSS/CDDP/HSA-MTX NPs had good biocompatibility and stability in physiological solutions. Furthermore, SPIO@PSS/CDDP/HSA-MTX NPs exhibited a higher temperature increase rate than SPIO nanoparticles under irradiation by a radiofrequency (RF) generator. Therefore, SPIO@PSS/CDDP/HSA-MTX NPs could be used as a hyperthermia inducer under RF exposure after nanoparticles preferentially targeted and then accumulated at tumor sites. In addition, SPIO@PSS/CDDP/HSA-MTX NPs were developed to be used during combined chemotherapy and hyperthermia therapy, exhibiting a synergistic anticancer effect better than the effect of monotherapy. CONCLUSION: Both in vitro and in vivo results suggest that the designed SPIO@PSS/CDDP/HSA-MTX NPs are a powerful candidate nanoplatform for future antitumor treatment strategies.
Asunto(s)
Óxido Ferrosoférrico/química , Hipertermia Inducida , Neoplasias Pulmonares/terapia , Nanomedicina/métodos , Animales , Línea Celular Tumoral , Cisplatino/química , Cisplatino/uso terapéutico , Terapia Combinada , Portadores de Fármacos/química , Humanos , Neoplasias Pulmonares/tratamiento farmacológico , Metotrexato/química , Nanopartículas/química , Albúmina Sérica/químicaRESUMEN
Helicobacter pylori infection is one of the leading causes of several gastroduodenal diseases, such as gastritis, peptic ulcer, and gastric cancer. In fact, H. pylori eradication provides a preventive effect against the incidence of gastric cancer. Amoxicillin is a commonly used antibiotic for H. pylori eradication. However, due to its easy degradation by gastric acid, it is necessary to administer it in a large dosage and to combine it with other antibiotics. This complexity and the strong side effects of H. pylori eradication therapy often lead to treatment failure. In this study, the chitosan/poly (acrylic acid) particles co-loaded with superparamagnetic iron oxide nanoparticles and amoxicillin (SPIO/AMO@PAA/CHI) are used as drug nano-carriers for H. pylori eradication therapy. In vitro and in vivo results show that the designed SPIO/AMO@PAA/CHI nanoparticles are biocompatible and could retain the biofilm inhibition and the bactericidal effect of amoxicillin against H. pylori. Moreover, the mucoadhesive property of chitosan allows SPIO/AMO@PAA/CHI nanoparticles to adhere to the gastric mucus layer and rapidly pass through the mucus layer after exposure to a magnetic field. When PAA is added, it competes with amoxicillin for chitosan, so that amoxicillin is quickly and continuously released between the mucus layer and the gastric epithelium and directly acts on H. pylori. Consequently, the use of this nano-carrier can extend the drug residence time in the stomach, reducing the drug dose and treatment period of H. pylori eradication therapy.
Asunto(s)
Amoxicilina/farmacología , Antibacterianos/uso terapéutico , Infecciones por Helicobacter/tratamiento farmacológico , Helicobacter pylori/efectos de los fármacos , Nanopartículas de Magnetita/química , Resinas Acrílicas/química , Amoxicilina/química , Amoxicilina/uso terapéutico , Animales , Antibacterianos/química , Antibacterianos/farmacología , Materiales Biocompatibles/química , Materiales Biocompatibles/metabolismo , Materiales Biocompatibles/farmacología , Materiales Biocompatibles/uso terapéutico , Biopelículas/efectos de los fármacos , Línea Celular , Quitosano/química , Portadores de Fármacos/química , Portadores de Fármacos/metabolismo , Compuestos Férricos/química , Mucosa Gástrica/metabolismo , Mucosa Gástrica/patología , Infecciones por Helicobacter/microbiología , Infecciones por Helicobacter/veterinaria , Helicobacter pylori/aislamiento & purificación , Helicobacter pylori/fisiología , Humanos , Campos Magnéticos , Ratones , Ratones Endogámicos BALB C , Factores de TiempoRESUMEN
Simultaneously interrogation of multiple nuclei has been of interest since the very earliest days of MRI [1]-[3]. Our group and several others are revisiting this topic [4]-[6]. Very fast broadband electronics make it possible to digitize a wide spectrum, including multiple nuclei, but this places great demands on data throughput. Another issue is that there can be great variance between RF preamplifier gain required for the different nuclei. To overcome the data problem, it is desirable to use undersampling, but this requires passband filtering around the resonant frequency of each nuclei. Here we present a frequency agile front end that provides separate data paths for each nucleus, either from a single coil or from multiple ports, allows independent gain, filters each using very flexible transmission line filtering, and then combines them back for undersampling.